Download App

Log in to access Online Inquiry
Company Overview More
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company’s enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition for Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.
CEO: Baxter F.C.M.A., FCMA, Jeffery R.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > VBIV VBI Vaccines > Detailed Quotes

VBIV VBI Vaccines

0.960-0.010-1.01%
Trading Session 05/19 14:06 ET
High
1.020
Open
0.972
Turnover
1.56M
Low
0.955
Pre Close
0.970
Volume
1.60M
Market Cap
247.95M
P/E(TTM)
Loss
52wk High
4.310
Shares
258.26M
P/E(Static)
Loss
52wk Low
0.950
Float Cap
183.84M
Bid/Ask %
-33.33%
Historical High
114.000
Shs Float
191.48M
Volume Ratio
0.93
Historical Low
0.400
Dividend TTM
--
Div Yield TTM
--
P/B
1.91
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.83%
Amplitude
6.70%
Avg Price
0.978
Lot Size
1
Float Cap
183.84M
Bid/Ask %
-33.33%
Historical High
114.000
Shs Float
191.48M
Volume Ratio
0.93
Historical Low
0.400
Dividend TTM
--
P/B
1.91
Dividend LFY
--
Turnover Ratio
0.83%
Amplitude
6.70%
Avg Price
0.978
Lot Size
1
Price Forecast

No Data

News

Comment